vs

Enact Holdings, Inc.(ACT)与Hims & Hers Health, Inc.(HIMS)财务数据对比。点击上方公司名可切换其他公司

Hims & Hers Health, Inc.的季度营收约是Enact Holdings, Inc.的1.9倍($608.1M vs $312.1M),Hims & Hers Health, Inc.同比增速更快(3.8% vs 1.7%),过去两年Hims & Hers Health, Inc.的营收复合增速更高(38.8% vs 2.2%)

Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商,为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案,帮助首付较低的购房者获得可负担的住房贷款,助力更多美国普通消费者实现安居需求。

Hims & Hers Health, Inc.是2017年成立的美国远程医疗企业,面向消费者提供处方药品、非处方药物以及各类个人护理产品,依托线上服务模式为用户打造便捷的健康消费渠道,覆盖日常医疗、个护等多场景需求。

ACT vs HIMS — 直观对比

营收规模更大
HIMS
HIMS
是对方的1.9倍
HIMS
$608.1M
$312.1M
ACT
营收增速更快
HIMS
HIMS
高出2.0%
HIMS
3.8%
1.7%
ACT
两年增速更快
HIMS
HIMS
近两年复合增速
HIMS
38.8%
2.2%
ACT

损益表 — Q1 FY2026 vs Q1 FY2026

指标
ACT
ACT
HIMS
HIMS
营收
$312.1M
$608.1M
净利润
$168.0M
毛利率
65.2%
营业利润率
21.9%
净利率
53.8%
营收同比
1.7%
3.8%
净利润同比
1.2%
每股收益(稀释后)
$1.18
$-0.40

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
ACT
ACT
HIMS
HIMS
Q1 26
$312.1M
$608.1M
Q4 25
$312.7M
$617.8M
Q3 25
$311.5M
$599.0M
Q2 25
$304.9M
$544.8M
Q1 25
$306.8M
$586.0M
Q4 24
$301.8M
$481.1M
Q3 24
$309.6M
$401.6M
Q2 24
$298.8M
$315.6M
净利润
ACT
ACT
HIMS
HIMS
Q1 26
$168.0M
Q4 25
$20.6M
Q3 25
$15.8M
Q2 25
$42.5M
Q1 25
$49.5M
Q4 24
$26.0M
Q3 24
$75.6M
Q2 24
$13.3M
毛利率
ACT
ACT
HIMS
HIMS
Q1 26
65.2%
Q4 25
71.9%
Q3 25
73.8%
Q2 25
76.4%
Q1 25
73.5%
Q4 24
76.8%
Q3 24
79.2%
Q2 24
81.3%
营业利润率
ACT
ACT
HIMS
HIMS
Q1 26
21.9%
Q4 25
71.3%
1.5%
Q3 25
67.4%
2.0%
Q2 25
70.4%
4.9%
Q1 25
68.9%
9.9%
Q4 24
68.9%
3.9%
Q3 24
74.1%
5.6%
Q2 24
78.6%
3.5%
净利率
ACT
ACT
HIMS
HIMS
Q1 26
53.8%
Q4 25
3.3%
Q3 25
2.6%
Q2 25
7.8%
Q1 25
8.4%
Q4 24
5.4%
Q3 24
18.8%
Q2 24
4.2%
每股收益(稀释后)
ACT
ACT
HIMS
HIMS
Q1 26
$1.18
$-0.40
Q4 25
$1.23
$0.08
Q3 25
$1.10
$0.06
Q2 25
$1.11
$0.17
Q1 25
$1.08
$0.20
Q4 24
$1.05
$0.10
Q3 24
$1.15
$0.32
Q2 24
$1.16
$0.06

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
ACT
ACT
HIMS
HIMS
现金及短期投资手头流动性
$549.0M
$222.3M
总债务越低越好
$744.9M
股东权益账面价值
$5.3B
$446.2M
总资产
$7.0B
$2.3B
负债/权益比越低杠杆越低
0.14×

8季度趋势,按日历期对齐

现金及短期投资
ACT
ACT
HIMS
HIMS
Q1 26
$549.0M
$222.3M
Q4 25
$582.5M
$228.6M
Q3 25
$545.6M
$345.8M
Q2 25
$616.0M
$1.1B
Q1 25
$639.0M
$273.7M
Q4 24
$602.8M
$220.6M
Q3 24
$674.9M
$165.5M
Q2 24
$711.3M
$129.3M
总债务
ACT
ACT
HIMS
HIMS
Q1 26
$744.9M
Q4 25
$744.5M
Q3 25
$744.1M
Q2 25
$743.8M
Q1 25
$743.4M
Q4 24
$743.0M
Q3 24
$742.7M
Q2 24
$742.4M
股东权益
ACT
ACT
HIMS
HIMS
Q1 26
$5.3B
$446.2M
Q4 25
$5.4B
$540.9M
Q3 25
$5.3B
$581.0M
Q2 25
$5.2B
$562.7M
Q1 25
$5.1B
$549.3M
Q4 24
$5.0B
$476.7M
Q3 24
$5.0B
$440.1M
Q2 24
$4.8B
$362.0M
总资产
ACT
ACT
HIMS
HIMS
Q1 26
$7.0B
$2.3B
Q4 25
$6.9B
$2.2B
Q3 25
$6.9B
$2.2B
Q2 25
$6.8B
$1.9B
Q1 25
$6.7B
$891.7M
Q4 24
$6.5B
$707.5M
Q3 24
$6.6B
$602.3M
Q2 24
$6.3B
$480.5M
负债/权益比
ACT
ACT
HIMS
HIMS
Q1 26
0.14×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.14×
Q1 25
0.15×
Q4 24
0.15×
Q3 24
0.15×
Q2 24
0.15×

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
ACT
ACT
HIMS
HIMS
经营现金流最新季度
$89.4M
自由现金流经营现金流 - 资本支出
$53.0M
自由现金流率自由现金流/营收
8.7%
资本支出强度资本支出/营收
现金转化率经营现金流/净利润
过去12个月自由现金流最近4个季度
$60.3M

8季度趋势,按日历期对齐

经营现金流
ACT
ACT
HIMS
HIMS
Q1 26
$89.4M
Q4 25
$724.5M
$61.3M
Q3 25
$192.0M
$148.7M
Q2 25
$119.5M
$-19.1M
Q1 25
$226.7M
$109.1M
Q4 24
$686.3M
$86.4M
Q3 24
$188.1M
$85.3M
Q2 24
$144.7M
$53.6M
自由现金流
ACT
ACT
HIMS
HIMS
Q1 26
$53.0M
Q4 25
$-2.5M
Q3 25
$79.3M
Q2 25
$-69.5M
Q1 25
$50.1M
Q4 24
$59.5M
Q3 24
$79.4M
Q2 24
$47.6M
自由现金流率
ACT
ACT
HIMS
HIMS
Q1 26
8.7%
Q4 25
-0.4%
Q3 25
13.2%
Q2 25
-12.8%
Q1 25
8.5%
Q4 24
12.4%
Q3 24
19.8%
Q2 24
15.1%
资本支出强度
ACT
ACT
HIMS
HIMS
Q1 26
Q4 25
10.3%
Q3 25
11.6%
Q2 25
9.3%
Q1 25
10.1%
Q4 24
5.6%
Q3 24
1.5%
Q2 24
1.9%
现金转化率
ACT
ACT
HIMS
HIMS
Q1 26
Q4 25
2.98×
Q3 25
9.43×
Q2 25
-0.45×
Q1 25
2.20×
Q4 24
3.32×
Q3 24
1.13×
Q2 24
4.03×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

ACT
ACT

Premiums$242.8M78%
Other$69.2M22%

HIMS
HIMS

United States Revenue$529.9M87%
Rest of the World Revenue$78.2M13%

相关对比